Our Story
DiagnoX was born from a deeply personal experience. Our founder, Dr. Sarah Chen, watched her father struggle with diabetes for over a decade. The daily finger pricks, the constant worry about glucose levels, and the fear of hypoglycemic episodes became a defining part of their family's life.
In 2018, after her father's third severe hypoglycemic episode, Dr. Chen made a promise: she would find a way to make glucose monitoring painless, precise, and continuous. With a team of world-class engineers, medical professionals, and researchers, she set out to develop technology that could read glucose levels through the skin without any invasive procedures.
After seven years of intensive research, clinical trials, and refinement, DiagnoX emerged as the world's first clinically-validated, non-invasive glucose monitoring device. Our patented optical sensor technology uses advanced light wavelengths and AI-powered analysis to deliver medical-grade accuracy without a single drop of blood.
Today, DiagnoX represents more than just a medical device—it's a symbol of hope for the 422 million people worldwide living with diabetes. It's proof that innovation, determination, and compassion can transform lives and create a better future for generations to come.